Phase II Study: The Outcome of Hypofractionated Involved-Field Radiation Therapy With Concurrent Chemotherapy for the Treatment of Locally Advanced Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

Phase II Study: The Outcome of Hypofractionated Involved-Field Radiation Therapy With Concurrent Chemotherapy for the Treatment of Locally Advanced Non-small Cell Lung Cancer

Published:2021-01 Issue:1 Volume:11 Page:35-43
ISSN:1879-8500
Container-title:Practical Radiation Oncology
language:en
Short-container-title:Practical Radiation Oncology

Author:

Katsuta Tsuyoshi^ORCID,Matsuura Kanji,Kashiwado Kozo,Kagemoto Masayuki

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference31 articles.

1. Trends in stage distribution for patients with non-small cell lung cancer: A National Cancer Database survey;Morgensztern;J Thorac Oncol,2010

2. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

3. Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117;Bradley;J Clin Oncol,2010

4. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypofractionation for Lung Tumors (Primary Malignant, Secondary Malignant);Hypofractionated and Stereotactic Radiation Therapy;2024

2. Outcomes of Image-Guided Moderately Hypofractionated Radiotherapy for Stage III Non-Small-Cell Lung Cancer;Journal of Oncology;2021-11-30

3. Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients;Japanese Journal of Clinical Oncology;2021-10-08